Evidence map›Paper›PMID 34658548›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Prognostication Based on Texture Analysis of Baseline

Akshima Sharma, Anil Kumar Pandey, Anshul Sharma, Geetanjali Arora, Anant Mohan, Ashu Seith Bhalla, Lalit Gupta, Shiba Kalyan Biswal, Rakesh Kumar

Abstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akshima SharmaDepartment of Nuclear Medicine, AIIMS, New Delhi, India.
Anil Kumar PandeyDepartment of Nuclear Medicine, AIIMS, New Delhi, India.
Anshul SharmaDepartment of Nuclear Medicine, AIIMS, New Delhi, India.
Geetanjali AroraDepartment of Nuclear Medicine, AIIMS, New Delhi, India.
Anant MohanDepartment of Pulmonary Medicine and Sleep Disorders, AIIMS, New Delhi, India.
Ashu Seith BhallaDepartment of Radio Diagnosis, AIIMS, New Delhi, India.
Lalit GuptaDepartment of Radio Diagnosis, AIIMS, New Delhi, India.
Shiba Kalyan BiswalDepartment of Pulmonary Medicine and Sleep Disorders, AIIMS, New Delhi, India.
Rakesh KumarDepartment of Nuclear Medicine, AIIMS, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOur study aims to establish the potential for tumor heterogeneity evaluated using MATERIALS AND

methodsA total of 42 patients (34 male and 8 female) with biopsy-proven NSCLC and mean age 55.33 ± 10.71 years who underwent a baseline F-18 FDG PET/CT and received platinum-based chemotherapy as first-line treatment were retrospectively included in the study. Ten first order, 21 s order texture parameters and 7 SUV and metabolic tumor volume (MTV) based metabolic parameters were calculated. All these parameters were compared between the two survival groups based on OS ≥1 year and OS <1 year. Cut-offs of significant parameters were determined using receiver operating characteristic curve analysis. Survival patterns were compared by log-rank test and presented using Kaplan-Meier curves. Cox proportion hazard model was used to determine the independent prognostic marker for 1 year OS.

resultsIn univariate survival analysis, 3 first order texture parameters (i.e. mean, median, root mean square with hazard ratios [HRs] 2.509 [

conclusionTexture analysis based on F-18 FDG PET/CT is potentially beneficial in the prediction of OS ≥1 year in NSCLC patients undergoing platinum-based chemotherapy as first-line treatment. Thus, can be used to stratify the patients which will not be benefitted with platinum-based chemotherapy and essentially needs to undergo some other therapy option.

Indexed as

18F Fludeoxyglucose positron emission tomography/computed tomographyoverall survival in nonsmall-cell lung carcinomatexture analysis

Identifiers

PMID34658548
PMCPMC8481851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.